Separately from clinical science, a report described intensifying enforcement around hospital contracting practices, including a DOJ lawsuit involving OhioHealth and NewYork-Presbyterian Hospital. The cases allege “all-or-nothing” contracting tactics that limit competition and keep healthcare prices high, signaling heightened scrutiny of how health systems shape insurance networks and patient access. While not a drug or device decision, contracting structures can affect patient throughput, network inclusion, and ultimately where biotech therapeutics reach populations. The enforcement action also highlights the growing role of regulators in reviewing the mechanics of healthcare delivery and pricing, not just clinical outcomes.